Dautzenberg F M, Py-Lang G, Higelin J, Fischer C, Wright M B, Huber G
F. Hoffmann-La Roche Ltd., Pharma Division, Preclinical Research, Basel, Switzerland.
J Pharmacol Exp Ther. 2001 Jan;296(1):113-20.
The binding characteristics of corticotropin-releasing factor (CRF) type 1 (CRF(1)) and type 2 (CRF(2)) receptors from human (hCRF(1) and hCRF(2alpha)) and Xenopus (xCRF(1) and xCRF(2)) were compared using four different (125)I-labeled CRF analogs, the agonists (125)I-CRF and (125)I-sauvagine, and the antagonists (125)I-astressin ((125)I-AST) and (125)I-antisauvagine-30 ((125)I-aSVG). The hCRF(2alpha) and xCRF(2) receptors bound all four radioligands with different affinities, whereas hCRF(1) did not bind (125)I-aSVG, and xCRF(1) bound neither (125)I-sauvagine nor (125)I-aSVG. Competitive binding studies using unlabeled agonists and antagonists with hCRF(1) and hCRF(2alpha) receptors revealed that most agonists exhibited higher affinity in displacing agonist radioligands compared with displacement of antagonist radioligands. Exceptions were the agonists human and rat urocortin, which displayed high-affinity binding in the presence of either (125)I-labeled agonist or antagonist ligands. In contrast, the affinities of antagonists were independent of the nature of the radioligand. We also found that, in contrast to the mammalian CRF receptors, the affinity of ligand binding to xCRF(1) and xCRF(2) receptors strongly depended on the nature of the radioligand used for competition. For xCRF(1), competitors showed different rank order binding profiles with (125)I-CRF compared with (125)I-AST as the displaceable ligand. Similarly, binding of competitors to the xCRF(2) receptor showed markedly different profiles with (125)I-CRF as the competed ligand compared with the other radioligands. These data demonstrate that amphibian CRF receptors have distinctly different binding modes compared with their mammalian counterparts.
使用四种不同的碘 - 125标记的促肾上腺皮质激素释放因子(CRF)类似物、激动剂碘 - 125 - CRF和碘 - 125 - 铃蟾肽,以及拮抗剂碘 - 125 - 阿斯特辛(碘 - 125 - AST)和碘 - 125 - 抗铃蟾肽 - 30(碘 - 125 - aSVG),比较了人源(hCRF(1)和hCRF(2α))和非洲爪蟾源(xCRF(1)和xCRF(2))的CRF 1型(CRF(1))和2型(CRF(2))受体的结合特性。hCRF(2α)和xCRF(2)受体以不同亲和力结合所有四种放射性配体,而hCRF(1)不结合碘 - 125 - aSVG,xCRF(1)既不结合碘 - 125 - 铃蟾肽也不结合碘 - 125 - aSVG。使用未标记的激动剂和拮抗剂对hCRF(1)和hCRF(2α)受体进行的竞争性结合研究表明,与拮抗剂放射性配体的置换相比,大多数激动剂在置换激动剂放射性配体时表现出更高的亲和力。例外情况是激动剂人尿皮质素和大鼠尿皮质素,它们在存在碘 - 125标记的激动剂或拮抗剂配体时都表现出高亲和力结合。相反,拮抗剂的亲和力与放射性配体的性质无关。我们还发现,与哺乳动物的CRF受体不同,配体与xCRF(1)和xCRF(2)受体结合的亲和力强烈依赖于用于竞争的放射性配体的性质。对于xCRF(1),与以碘 - 125 - AST作为可置换配体相比,竞争者与碘 - 125 - CRF显示出不同的结合顺序谱。同样,与其他放射性配体相比,以碘 - 125 - CRF作为被竞争配体时,竞争者与xCRF(2)受体的结合显示出明显不同的谱。这些数据表明,两栖动物的CRF受体与其哺乳动物对应物相比具有明显不同的结合模式。